Iopamidol

Iopamidol, also known by the brand name Isovue, is a contrast agent used in medical imaging procedures like CT scans and angiography. This article examines several clinical trials that have investigated the safety, efficacy, and optimal use of iopamidol for various imaging applications. The studies look at factors like image quality, patient comfort, and potential side effects when using iopamidol compared to other contrast agents or at different doses and temperatures.

Table of Contents

What is Iopamidol?

Iopamidol is a medical substance known as a contrast agent or contrast medium. It’s used to improve the visibility of internal body structures during certain imaging procedures, particularly in X-ray based examinations like Computed Tomography (CT) scans. Iopamidol is part of a class of contrast agents called non-ionic, low-osmolar iodinated contrast media[1].

This medication is also known by several other names, including:

  • Isovue
  • Iopamidol injection
  • Isovue-370

These alternative names may be used interchangeably by healthcare providers, but they all refer to the same substance[1][2].

Uses of Iopamidol

Iopamidol is used in various medical imaging procedures to enhance the visibility of blood vessels, organs, and other internal structures. Some of the common uses include:

  1. Coronary CT Angiography (CCTA): This is a non-invasive heart imaging test used to evaluate the coronary arteries for potential blockages or narrowing (stenosis). Iopamidol helps to make the blood vessels more visible on the CT images[3].
  2. Abdominal and Pelvic CT Scans: Iopamidol can be used to enhance images of organs and structures in the abdomen and pelvis. It can be administered orally (by mouth) or intravenously (through a vein) depending on the specific area being examined[4].
  3. Percutaneous Coronary Intervention (PCI): This is a non-surgical procedure used to open blocked or narrowed coronary arteries. Iopamidol is used to make the blood vessels visible during the procedure[1].

How Iopamidol is Administered

The way Iopamidol is given depends on the type of imaging procedure being performed:

  • Intravenous (IV) injection: For many CT scans, Iopamidol is injected into a vein, usually in your arm. The dose is typically calculated based on your body weight, with common doses ranging from 0.5 to 2.0 mL per kilogram of body weight[5].
  • Oral administration: For some abdominal CT scans, you may be asked to drink a diluted solution of Iopamidol. This helps to visualize your gastrointestinal tract[4].

The exact dose and method of administration will be determined by your healthcare provider based on the specific imaging procedure and your individual needs.

Clinical Studies and Research

Iopamidol has been the subject of numerous clinical studies to evaluate its effectiveness and safety in various imaging procedures. Some notable research includes:

  • A study comparing Iopamidol to another contrast agent (Iodixanol) in patients undergoing CT scans of the abdomen and pelvis. This research aimed to evaluate patient comfort and image quality[6].
  • Research on the use of Iopamidol in coronary CT angiography, examining how the temperature of the contrast media affects image quality and the occurrence of adverse events[3].
  • Studies investigating the optimal dosing of Iopamidol based on a patient’s lean body weight rather than total body weight, which may lead to improved image quality and potentially reduced doses for some patients[5].

Potential Side Effects

While Iopamidol is generally considered safe, like all medications, it can cause side effects in some people. Potential side effects may include:

  • Allergic reactions: These can range from mild (such as itching or hives) to severe (such as difficulty breathing). Severe allergic reactions are rare but can be serious[3].
  • Feeling of warmth or coldness: Some patients report feeling a sensation of heat or cold when the contrast is injected[6].
  • Nausea or vomiting: These symptoms can occur, especially with oral administration.
  • Pain or discomfort: Some patients may experience discomfort at the injection site[6].

It’s important to inform your healthcare provider of any unusual symptoms you experience during or after the procedure.

Special Considerations

There are some special considerations to keep in mind when using Iopamidol:

  • Kidney function: If you have kidney problems, your doctor may need to adjust the dose or consider alternative imaging methods. Iopamidol and other iodinated contrast agents can potentially affect kidney function, especially in people with pre-existing kidney issues[1].
  • Thyroid function: In very young children (0-3 years), there’s a small risk that Iopamidol could affect thyroid function. Doctors may monitor thyroid function after the procedure in these cases[7].
  • Pregnancy and breastfeeding: If you’re pregnant or breastfeeding, make sure to inform your doctor before receiving Iopamidol.
  • Allergies: If you have a history of allergies, especially to iodine or contrast agents, it’s crucial to inform your healthcare provider before the procedure.

Remember, your healthcare provider will consider your individual circumstances when deciding whether Iopamidol is appropriate for you. Always discuss any concerns or questions you have about your imaging procedure with your doctor.

Study Focus Key Findings
Coronary CT Angiography Evaluated different doses (70, 80, 90 mL) of iopamidol for visualizing coronary arteries
Abdominal/Pelvic CT Compared patient comfort and image quality between iopamidol and iodixanol
Contrast Temperature Examined effects of room temperature vs body temperature iopamidol on image quality and adverse events
Pediatric Thyroid Function Monitored thyroid function in children 0-3 years old after iopamidol administration
Dosing Based on Body Weight Compared contrast dosing based on total body weight vs lean body weight
Peripheral Arteriography Evaluated patient comfort and image quality for iopamidol vs iodixanol in peripheral artery imaging

Ongoing Clinical Trials on Iopamidol

  • Study on Preventing Kidney Problems in Peripheral Arterial Disease Patients Using Carbon Dioxide and Iopamidol, Iomeprol, and Iopromide During Vascular Procedures

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Germany
  • Study of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Ireland

Glossary

  • Contrast agent: A substance used to enhance the visibility of internal body structures in medical imaging
  • CT (Computed Tomography): An imaging technique that uses X-rays and computer processing to create detailed cross-sectional images of the body
  • Angiography: An imaging technique used to visualize blood vessels and organs inside the body
  • Intravenous: Administered directly into a vein
  • Intra-arterial: Administered directly into an artery
  • Hounsfield Units (HU): A measure of radiodensity used in CT imaging
  • Coronary artery: Blood vessels that supply the heart muscle with oxygen-rich blood
  • Stenosis: Abnormal narrowing of a blood vessel or other tubular organ
  • Thyroid function: The ability of the thyroid gland to produce and regulate thyroid hormones
  • Hypothyroidism: A condition in which the thyroid gland doesn't produce enough thyroid hormone

References

  1. https://clinicaltrials.gov/study/NCT01136915
  2. https://clinicaltrials.gov/study/NCT01136876
  3. https://clinicaltrials.gov/study/NCT05489055
  4. https://clinicaltrials.gov/study/NCT04453059
  5. https://clinicaltrials.gov/study/NCT03384979
  6. https://clinicaltrials.gov/study/NCT01376089
  7. https://clinicaltrials.gov/study/NCT03779906